Data and Cohort updates (through Q1 2025):
26K GLP-1 Agonist Patients
Helix announced the launch of the largest GLP-1 clinico-genomic dataset in the world, encompassing data and insights from over 26K treated patients across the US
23K Autoimmune Patients
Helix announced the launch of an Autoimmune cohort, comprised of over 23k patients diagnosed with I&I conditions and inclusive of full lab data
Partnerships:
Helix-Komodo Health partnership to further enrich Helix's linked clinico-genomic datasets for research and life science partners. This partnership will add insights derived from medical, pharmacy and mortality data from Komodo's Healthcare Map®, the industry's most robust and precise view of longitudinal de-identified patient-level insights.
TriHealth, Parkview Health, and Rochester Regional Health have joined the Helix Research Network. Each health system has committed to enroll 100,000 participants, ultimately adding at least 300,000 new participants to the largest and fastest growing precision clinical research network in the world.
Research Roundup
GCK Variant Research
Helix researchers recently published a study in Nature which conducted a population-level assessment showing secondary complications in individuals with pathogenic and glucose-elevating GCK variants and T2D and suggests that genotyping for these variants should be considered in a precision medicine approach for T2D treatment and prevention.
ACMG 2025 Posters
Helix Researchers unveiled new clinical research from the Helix Research NetworkTM (HRN) and its partners at the 2025 ACMG Annual Clinical Genetics Meeting in Los Angeles, CA showcasing how genomic screening can not only accurately identify high-risk individuals but also improve adherence to recommended care. The novel research goes a step further to demonstrate how real-world evidence can ultimately enable precision medicine through personalized monitoring plans based on individual risk and improve and automate the interpretation of genetic variations for increased accuracy. Take a look at our latest research posters from ACMG.
